We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

31 hedge funds and large institutions have $224K invested in NKGen Biotech, Inc. Warrants in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

3% more funds holding

Funds holding: 30 → 31 (+1)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

35% less capital invested

Capital invested by funds: $346K → $224K (-$122K)

Holders
31
Holders Change
+1
Holders Change %
+3.33%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
4
Closed
1
Calls
$3K
Puts
–
Net Calls
+$3K
Net Calls Change
-$2K

Top Buyers

Rank Fund Capital Flow
1
FTUS
Flow Traders U.S.
New York
+$1.59K
2
CAC
Cowen and Company
New York
+$1.56K
3
SFA
Sequoia Financial Advisors
Ohio
+$1.47K
4
Citadel Advisors
Citadel Advisors
Florida
+$716
5
WAM
Wolverine Asset Management
Illinois
+$595

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$5.07K
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.14K
3
VF
Virtu Financial
New York
-$2K
4
TCA
Taconic Capital Advisors
New York
-$6
5
UBS Group
UBS Group
Switzerland
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Rivernorth Capital Management
Florida
$65.2K – – –
BNP Paribas Financial Markets
2
BNP Paribas Financial Markets
France
$14.8K – – –
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$14K -$2.14K -20,475 -11%
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$13.8K – – –
EAM
5
Exos Asset Management
New York
$13.3K – – –
SCM
6
Shaolin Capital Management
Florida
$11.2K – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
7
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$9.9K – – –
KL
8
KIM LLC
Kansas
$9.11K – – –
Jane Street
9
Jane Street
New York
$8.71K – – –
TCA
10
Taconic Capital Advisors
New York
$6.92K -$6 -58 -0.1%
PAMP
11
Polar Asset Management Partners
Ontario, Canada
$5.92K – – –
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$4.95K – – –
Walleye Capital
13
Walleye Capital
New York
$4.54K – – –
FBCM
14
Fort Baker Capital Management
California
$3.65K – – –
ACM
15
Atalaya Capital Management
New York
$3.6K – – –
AIMCA
16
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$3.48K – – –
CAC
17
Cowen and Company
New York
$3.46K +$1.56K +14,900 +60%
SCM
18
Saba Capital Management
New York
$3.07K – – –
MTCM
19
Mint Tower Capital Management
Netherlands
$3K – – –
SSA
20
Schonfeld Strategic Advisors
New York
$2.96K – – –
Citadel Advisors
21
Citadel Advisors
Florida
$2.63K +$716 +6,841 +35%
Walleye Trading
22
Walleye Trading
New York
$2.56K – – –
WAM
23
Wolverine Asset Management
Illinois
$2.45K +$595 +5,687 +25%
PC
24
Periscope Capital
Ontario, Canada
$1.89K -$5.07K -48,500 -72%
GCIA
25
Gabelli & Co Investment Advisers
New York
$1.5K – – –
1
2

NKGNW Hedge Fund Activity: Q2 2024 in Review

31 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q2 2024, worth a combined $224K — down 35% from $346K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new NKGNW positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Flow Traders U.S., opening a new position worth an estimated $1.59K. The largest seller was Periscope Capital, cutting an estimated $5.07K.

  • 31 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q2 2024, up from 30 in Q1 2024.
  • Funds reported $224K of NKGen Biotech, Inc. Warrants stock for Q2 2024, down 35% quarter-over-quarter.
  • 2 funds opened new NKGen Biotech, Inc. Warrants positions in Q2 2024 and 1 closed out, a net change of +1 holder.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q2 2024 was Flow Traders U.S., an estimated $1.59K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q2 2024 was Periscope Capital, an estimated $5.07K sold.

Based on aggregated 13F filings for Q2 2024.